"10.1371_journal.pone.0130641","plos one","2015-06-22T00:00:00Z","Hongxia Niu; Jinxiu Peng; Chunxiang Bai; Xun Liu; Lina Hu; Yanping Luo; Bingxiang Wang; Ying Zhang; Jianzhu Chen; Hongjuan Yu; Qiaoyang Xian; Bingdong Zhu","Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation & Lanzhou Center for Tuberculosis Research, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China; Institute of Pathogen Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China; Lanzhou Institute of Biological Products, Lanzhou, China; Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins Universityï¼ŒBaltimore, Maryland, United States of America; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; ABSL-3 Lab, Wuhan University, Wuhan, China","Conceived and designed the experiments: BZ. Performed the experiments: HN JP CB XL LH YL BW HY QX. Analyzed the data: HN. Contributed reagents/materials/analysis tools: BZ. Wrote the paper: HN BZ YZ JC.","The authors have applied for two patents on vaccine LT69 and adjuvant DDA-Poly I:C in china (Publication No. 2014101871546 and No. 201110199072.x), which relate to this study. These patents belong to Lanzhou University (China). All the authors have no financial conflict with each other and no conflict of interest exits in the submission of this manuscript.","2015","06","Hongxia Niu","HN",12,TRUE,1,9,1,4,TRUE,TRUE,FALSE,0,NA,FALSE
